Trading Tips Blog

Chief quality officer makes $71,000 buy and fund adds 1.5 million shares. Bryan Ball, Chief Quality Officer at Immunomedics (IMMU), bought 5,000 shares, paying around $71,000 to do so. This doubles his stake, following a similarly-sized buy back in June. Besides insider buying by officers, a number of funds have been accumulating shares as well, including a 1.5 million share buy by Avoro Capital Advisors in early October. The fund now owns over 21 million shares, or about 11 percent of the ...
Read More About This

60-fold surge in call-buying volume. With 8,900 contracts trading on the November 1st $29 call options on MGM Resorts International (MGM) saw a 60-fold surge in volume from its prior open interest of 150 contracts. With 25 days left to go, and with shares just over $27, the option trade will expire worthless unless shares rise to at least $29, or 7.4 percent. With the company reporting earnings the last week of October, shares could have a big enough bounce to move ...
Read More About This

Director makes million-dollar buy. Director James Star of Chewy Inc (CHWY) bought 41,521 shares recently, increasing his stake by 83 percent. At a cost just under $24 per share, the buy came to $994,000. This is the second insider buy at the company since it went public from PetSmart back in June. Since the IPO, no insiders have sold shares, and the insider who did sell shares at the IPO was a fund, not a member of the corporate staff or ...
Read More About This

Put buying suggests drop ahead. Over 2,600 contracts traded on the January $120 put options on The Howard Hughes Corporation (HHC), up from a volume of 100. That’s a 27-fold increase in volume, a very unusual move in a name that typically has little options activity. With shares at $126, shares need to drop nearly 5 percent for this option to move in-the-money. With 105 trading days to go, it’s a bet that could play out. The company, an owner, manager, and developer ...
Read More About This

Major fund adds to stake. Crestview Partners, a fund with board seats and major ownership, added to their stake of WideOpenWest (WOW). The fund bought 18,120 shares, increasing their total stake to over 30,547,000 shares, at a cost of $108,000. Insiders such as the CEO and CFO have also been buyers of the company in the past two years, with most of that buying coming in recent weeks. Insiders have last sold shares of the company back in 2017. WideOpenWest provides cable, ...
Read More About This

Bet on continued drop in shares. A number of bearish options trades were made against Ford Motors (F) recently, as the company reported lower-than-expected sales. Of all the options trades, the November 15th $8 puts saw the most action, with over 44,000 contracts trade, for a 63-fold surge in volume from a prior 700 contracts. That bet, expiring in about six weeks, will move in-the-money if shares drop just fifty cents, or about 6 percent from here. Ford announced that its auto ...
Read More About This

November put buying suggests further drop. The November 15th $8 put options on Teva Pharmaceutical (TEVA) saw over 17,000 contracts trade against a prior open interest of 243, indicating a 70-fold surge in volume on the trade. With shares of Teva around $7, the $8 puts are already $1 in-the-money and should move penny-for-penny with any further drop in shares. At a cost of $1.44, the option also has about a penny a day in time premium attached to it. Shares of Teva ...
Read More About This

Director makes $59 million buy. Charles Heilbronn picked up 243,849 shares of Ulta Beauty (ULTA), increasing his stake by 13 percent to just over 2,087,000 shares. The total cost for the latest purchase, with shares around $240, came to $58,900,000. This marks the second insider buy at the company this year, following a 1,300 shares buy from the CEO in late September. Insiders have otherwise been sellers of the company, at prices 21 to 26 percent higher than the current price. Although ...
Read More About This